Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Mefenamic Acid in Primary Dysmenorrhea
NCT02183025Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 1998
- Primary completion
- Apr 1999
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of meloxicam in primary dysmenorrhea (PD), sponsored by Boehringer Ingelheim. Started Jan 1998; status: completed.
02
Drugs
meloxicam
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT02183025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183025.